Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 9, 2023
A pilot sentinel surveillance system to monitor treatment and treatment outcomes of chronic hepatitis B and C infections in clinical centres in three European countries, 2019Anthony Nardone, Lina Nerlander, Erika Duffell, et al.
Influenza and Other Respiratory Viruses|November 28, 2025
Effectiveness of the 2023 Autumn XBB.1.5 COVID-19 Booster During Summer 2024 in the EU/EEA: A VEBIS Electronic Health Record Network StudyJames Humphreys, Nathalie Nicolay, Toon Braeye, et al.
Expert Review of Vaccines|November 13, 2024
Monovalent XBB.1.5 COVID-19 vaccine effectiveness against hospitalisations and deaths during the Omicron BA.2.86/JN.1 period among older adults in seven European countries: A VEBIS-EHR network studyBaltazar Nunes, James Humphreys, Nathalie Nicolay, et al.
Influenza and Other Respiratory Viruses|November 29, 2023
Monitoring COVID-19 vaccine effectiveness against COVID-19 hospitalisation and death using electronic health registries in ≥65 years old population in six European countries, October 2021 to November 2022Irina Kislaya, Alexis Sentís, Jostein Starrfelt, et al.
Epidemiology and Infection|March 16, 2025
Comparison of two methods for the estimation of COVID-19 vaccine effectiveness of the autumnal booster within the VEBIS-EHR network in 2022/23Susana Monge, James Humphreys, Nathalie Nicolay, et al.
Influenza and Other Respiratory Viruses|April 24, 2024
Effectiveness of XBB.1.5 Monovalent COVID-19 Vaccines During a Period of XBB.1.5 Dominance in EU/EEA Countries, October to November 2023: A VEBIS-EHR Network StudySusana Monge, James Humphreys, Nathalie Nicolay, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|January 5, 2024
Relative vaccine effectiveness against COVID-19 hospitalisation in persons aged ≥ 65 years: results from a VEBIS network, Europe, October 2021 to July 2023Mario Fontán-Vela, Esther Kissling, Nathalie Nicolay, et al.
BMJ Global Health|August 23, 2022
SARS-CoV-2 infection in Africa: a systematic review and meta-analysis of standardised seroprevalence studies, from January 2020 to December 2021Hannah C Lewis, Harriet Ware, Mairead Whelan, et al.
Trials|March 26, 2016
An analysis of baseline data from the PROUD study: an open-label randomised trial of pre-exposure prophylaxisDavid I Dolling, Monica Desai, Alan McOwan, et al.
Plos One|April 21, 2017
Acceptability of an open-label wait-listed trial design: Experiences from the PROUD PrEP studyMitzy Gafos, Elizabeth Brodnicki, Monica Desai, et al.
Pageof 9